IBDEI1IZ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27391,0)
 ;;=799.01^^163^1696^25
 ;;^UTILITY(U,$J,358.3,27391,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27391,1,4,0)
 ;;=4^799.01
 ;;^UTILITY(U,$J,358.3,27391,1,5,0)
 ;;=5^ASPHYXIA
 ;;^UTILITY(U,$J,358.3,27391,2)
 ;;=^11005
 ;;^UTILITY(U,$J,358.3,27392,0)
 ;;=799.21^^163^1696^95
 ;;^UTILITY(U,$J,358.3,27392,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27392,1,4,0)
 ;;=4^799.21
 ;;^UTILITY(U,$J,358.3,27392,1,5,0)
 ;;=5^NERVOUSNESS
 ;;^UTILITY(U,$J,358.3,27392,2)
 ;;=^338291
 ;;^UTILITY(U,$J,358.3,27393,0)
 ;;=799.4^^163^1696^31
 ;;^UTILITY(U,$J,358.3,27393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27393,1,4,0)
 ;;=4^799.4
 ;;^UTILITY(U,$J,358.3,27393,1,5,0)
 ;;=5^CACHEXIA
 ;;^UTILITY(U,$J,358.3,27393,2)
 ;;=^17920
 ;;^UTILITY(U,$J,358.3,27394,0)
 ;;=919.0^^163^1696^17
 ;;^UTILITY(U,$J,358.3,27394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27394,1,4,0)
 ;;=4^919.0
 ;;^UTILITY(U,$J,358.3,27394,1,5,0)
 ;;=5^ABRASION,NOT INFECTED
 ;;^UTILITY(U,$J,358.3,27394,2)
 ;;=^1305
 ;;^UTILITY(U,$J,358.3,27395,0)
 ;;=919.1^^163^1696^16
 ;;^UTILITY(U,$J,358.3,27395,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27395,1,4,0)
 ;;=4^919.1
 ;;^UTILITY(U,$J,358.3,27395,1,5,0)
 ;;=5^ABRASION,INFECTED
 ;;^UTILITY(U,$J,358.3,27395,2)
 ;;=^275358
 ;;^UTILITY(U,$J,358.3,27396,0)
 ;;=919.2^^163^1696^30
 ;;^UTILITY(U,$J,358.3,27396,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27396,1,4,0)
 ;;=4^919.2
 ;;^UTILITY(U,$J,358.3,27396,1,5,0)
 ;;=5^BLISTER,NOT INFECTED
 ;;^UTILITY(U,$J,358.3,27396,2)
 ;;=^15350
 ;;^UTILITY(U,$J,358.3,27397,0)
 ;;=919.3^^163^1696^29
 ;;^UTILITY(U,$J,358.3,27397,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27397,1,4,0)
 ;;=4^919.3
 ;;^UTILITY(U,$J,358.3,27397,1,5,0)
 ;;=5^BLISTER,INFECTED
 ;;^UTILITY(U,$J,358.3,27397,2)
 ;;=^275359
 ;;^UTILITY(U,$J,358.3,27398,0)
 ;;=V58.61^^163^1696^22
 ;;^UTILITY(U,$J,358.3,27398,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27398,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,27398,1,5,0)
 ;;=5^ANTICOAGULANT RX,LONG TERM
 ;;^UTILITY(U,$J,358.3,27398,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,27399,0)
 ;;=369.4^^163^1697^4
 ;;^UTILITY(U,$J,358.3,27399,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27399,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,27399,1,5,0)
 ;;=5^LEGAL BLINDNESS-USA DEF
 ;;^UTILITY(U,$J,358.3,27399,2)
 ;;=^268887
 ;;^UTILITY(U,$J,358.3,27400,0)
 ;;=369.00^^163^1697^3
 ;;^UTILITY(U,$J,358.3,27400,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27400,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,27400,1,5,0)
 ;;=5^BOTH EYES BLIND-WHO DEF
 ;;^UTILITY(U,$J,358.3,27400,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,27401,0)
 ;;=369.10^^163^1697^2
 ;;^UTILITY(U,$J,358.3,27401,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27401,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,27401,1,5,0)
 ;;=5^BLINDNESS/LOW VISION
 ;;^UTILITY(U,$J,358.3,27401,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,27402,0)
 ;;=369.20^^163^1697^5
 ;;^UTILITY(U,$J,358.3,27402,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27402,1,4,0)
 ;;=4^369.20
 ;;^UTILITY(U,$J,358.3,27402,1,5,0)
 ;;=5^LOW VISION, 2 EYES NOS
 ;;^UTILITY(U,$J,358.3,27402,2)
 ;;=^71924
 ;;^UTILITY(U,$J,358.3,27403,0)
 ;;=369.3^^163^1697^1
 ;;^UTILITY(U,$J,358.3,27403,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27403,1,4,0)
 ;;=4^369.3
 ;;^UTILITY(U,$J,358.3,27403,1,5,0)
 ;;=5^BLINDNESS NOS, BOTH EYES
 ;;^UTILITY(U,$J,358.3,27403,2)
 ;;=^268886
 ;;^UTILITY(U,$J,358.3,27404,0)
 ;;=438.21^^163^1698^3
 ;;^UTILITY(U,$J,358.3,27404,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27404,1,4,0)
 ;;=4^438.21
 ;;^UTILITY(U,$J,358.3,27404,1,5,0)
 ;;=5^HEMIPLEGIA DOM SIDE S/P CVA
